Premium Information is available for this item - Upgrade for $1 a day
6505-01-201-0809
Theophylline Extended-Release Tablets
6505012010809 012010809 NDC00049-2200-66 SUSTAIRE TABLETS
January 2023
4
Marketplace 6505-01-201-0809
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-201-0809 5+ Documents (More...)
RQST NE Updated Every Day 6505-01-201-0809 RQST Updated Every Day 6505-01-201-0809 RQST NE Related Documents
6505-01-201-0809 5+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-201-0809
093-9477 6505-99-212-8295 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-201-0809 Theophylline
-9477 https//www.nsnlookup.com 6505-99-212-8295 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-201-0809
Extended-Release Tablets www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-135-3174 https 6505/us 6505-01-201-0809
fsg-65/fsc-6505/us 6505-01-268-7538 Theophylline Extended-Release Tablets 011353174 CONSTANT-T 6505-01-201-0809
Theophylline Extended-Release Tablets 6505-99-212-8295 https/ 6505-01-201-0809 https https//www.nsnlookup.com
Extended-Release Tablets www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-083-6613 https 6505/us 6505-01-201-0809
Extended-Release Tablets www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-135-3174 https 6505/us 6505-01-201-0809
fsg-65/fsc-6505/us 6505-01-268-7538 6505-01-083-6613 https 6505/us 6505-01-201-0809 https//www.nsnlookup.com
Restrictions 6505-01-201-0809
6505-01-201-0809 is a Theophylline Extended-Release Tablets that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
Import and Export 6505-01-201-0809
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-201-0809
- MOE Rule:
- V542
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-201-0809
- Part Number
- Manufacturer
- Status
- NDC00049-2200-66
- Manufacturer
- 04517 - Roerig Div Pfizer Inc (Active)
- Incomplete Reference
- Incomplete Reference
- SUSTAIRE TABLETS
- 04517 - Roerig Div Pfizer Inc (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
Datasheet 6505-01-201-0809
- Characteristic
- Specifications
- FIIG
- Specifications
- A510N0
- Active Medicament Medicinal Strength [AKJA]
- 100.000 Milligrams Theophylline Active Ingredient
- Primary Container Type [CQCT]
- Bottle
- Primary Container Content Quantity [CRLK]
- 100.000 Tablets
- Special Features [FEAT]
- Long Action Method:Extended Release;
Management Data 6505-01-201-0809
- Effective Date
- Organization
- Unit of Issue
- Unit Price
- Qty Unit Pack
- Unit of Issue
- Feb 1985
- Veterans Administration (VA)
- BT
- Subscribe
- BT
- MOE
- USC
- Code
- Statement
- Order of Use
- Jump To Code
- Qty Per Assy
- UOM
- Technical Document
- Quantative Expression
- Code
- Veterans Administration (VA)
- V
- K
- U/I Contains 100 Tt
- 00000000100TT
- K
NATO Stock Numbers Related to 6505-01-201-0809
Freight Information 6505-01-201-0809
6505-01-201-0809 has freight characteristics.. 6505-01-201-0809 has a variance between NMFC and UFC when transported by rail and the description should be consulted.